NOV-25-13 The U.S. Department of Health and Human Services, the White House Initiative on Asian Americans and Pacific Islander and Hep B United are cohosting a webinar on hepatitis B and reducing perinatal transmission on Thursday, December 19, from 2:30-4:00PM EDT. The webinar will discuss new tools and best practices toward reducing hepatitis B health disparities in Asian American and Pacific Islander communities, including potential interventions in prenatal care, information about gaps in reporting and a new resource from the Immunization Action Coalition entitled, Give Birth to the End of Hep B. To register, click here.
Global Surveillance of Antiretroviral Drug Safety
Considerable progress has been made in providing global access to antiretroviral therapy. However, the effectiveness of treatment programs risks being compromised by problems related to toxicity, intolerance, drug-drug interactions, diversion, counterfeiting, inappropriate drug utilization and other issues. These are examples of common phenomena affecting individual patients and public health, but not identified before clinical use and scarcely systematically reported in countries with limited infrastructures for monitoring of drug use and safety.
This meeting was convened on June 11, 2010, in Washington, DC, with support from the Bill and Melinda Gates Foundation. Meeting participants included representatives from governments, global health organizations, industry, regulatory agencies, foundations, academia and implementers.
Multiple efforts are underway to improve antiretroviral drug (ARV) surveillance systems in low- and middle-income countries. All stakeholders must be engaged to ensure collaboration. The goal of this meeting is to convene these stakeholders to achieve synergy.
Nyasha Bakare, MD, MPH